AJP - Endocrinology and Metabolism, Vol 265, Issue 1 E61-E67, Copyright © 1993 by American Physiological Society

ARTICLES

Insulin differentially regulates systemic and skeletal muscle vascular resistance

A. D. Baron and G. Brechtel
Department of Medicine, Indiana University Medical Center, Indianapolis, Indiana 46202.

To explore the relationships among insulin action, vascular resistance, and insulin sensitivity, we studied three groups of lean (Ln) and one group of obese (Ob) men. Glucose uptake was measured in whole body (WBGU) and in leg muscle (LGU) under basal and hyperinsulinemic euglycemic conditions. Mean arterial pressure (MAP), cardiac output (CO), leg blood flow (LBF), and systemic (SVR) and leg (LVR) vascular resistance were also ascertained. Ln groups were studied during insulin infusion rates of 20, 40, and 600 mU.m-2.min-1 and the Ob group at 40 mU.m-2.min-1. In Ob vs. Ln groups, WBGU and LGU were reduced by 51 (P < 0.01) and 42% (P < 0.05), respectively. In response to insulin, LBF increased > 60% (P < 0.01) in Ln groups but only approximately 20% in the Ob group, P = not significant (NS). CO was unchanged in Ob compared with a 15% increase (P < 0.05) in Ln groups, LBF was highly correlated with CO, r 0.70, P < 0.001. During hyperinsulinemia, MAP and LVR decreased in Ln (P < 0.001) but not in the Ob group (P = NS). In Ln groups, SVR decreased by 26 vs. 9% in the Ob group, P < 0.01. In summary, 1) insulin decreases LVR more than SVR and via this mechanism redistributes CO to insulin-sensitive tissues, 2) this insulin effect is blunted in Ob humans, and 3) insulin decreases MAP and vascular resistance more effectively in insulin-sensitive than in insulin-resistant subjects. In conclusion, insulin resistance to carbohydrate metabolism is associated with resistance to insulin's effect to decrease skeletal muscle vascular resistance and as such could act as a risk factor for the development of hypertension.

This article has been cited by other articles:

				C. M. Brown, A. G. Dulloo, G. Yepuri, and J.-P. Montani Fructose ingestion acutely elevates blood pressure in healthy young humans Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R730 - R737. [Abstract] [Full Text] [PDF]

				L. H. Clerk, M. A. Vincent, E. J. Barrett, M. F. Lankford, and J. R. Lindner Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiogensin-converting enzyme inhibition Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1804 - E1809. [Abstract] [Full Text] [PDF]

				M. A. Vincent, L. H. Clerk, J. R. Lindner, W. J. Price, L. A. Jahn, H. Leong-Poi, and E. J. Barrett Mixed meal and light exercise each recruit muscle capillaries in healthy humans Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1191 - E1197. [Abstract] [Full Text] [PDF]

				D. A. Guy, D. Sandoval, M. A. Richardson, D. Tate, P. J. Flakoll, and S. N. Davis Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E178 - E186. [Abstract] [Full Text] [PDF]

				M. A. Vincent, E. J. Barrett, J. R. Lindner, M. G. Clark, and S. Rattigan Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E123 - E129. [Abstract] [Full Text] [PDF]

				T. Doenst, W. Bothe, and F. Beyersdorf Therapy with insulin in cardiac surgery: controversies and possible solutions Ann. Thorac. Surg., February 1, 2003; 75(2): S721 - 728. [Abstract] [Full Text] [PDF]

				M. G. Clark, M. G. Wallis, E. J. Barrett, M. A. Vincent, S. M. Richards, L. H. Clerk, and S. Rattigan Blood flow and muscle metabolism: a focus on insulin action Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E241 - E258. [Abstract] [Full Text] [PDF]

				E. H. Serne, R. G. IJzerman, R. O.B. Gans, R. Nijveldt, G. de Vries, R. Evertz, A. J.M. Donker, and C. D.A. Stehouwer Direct Evidence for Insulin-Induced Capillary Recruitment in Skin of Healthy Subjects During Physiological Hyperinsulinemia Diabetes, May 1, 2002; 51(5): 1515 - 1522. [Abstract] [Full Text] [PDF]

				J. Sundell, P. Nuutila, H. Laine, M. Luotolahti, K. Kalliokoski, O. Raitakari, and J. Knuuti Dose-Dependent Vasodilating Effects of Insulin on Adenosine-Stimulated Myocardial Blood Flow Diabetes, April 1, 2002; 51(4): 1125 - 1130. [Abstract] [Full Text] [PDF]

				R. P. Hoffman, C. A. Sinkey, J. M. Dopp, and B. G. Phillips Systemic and Local Adrenergic Regulation of Muscle Glucose Utilization During Hypoglycemia in Healthy Subjects Diabetes, March 1, 2002; 51(3): 734 - 742. [Abstract] [Full Text] [PDF]

				R. R. Russell III, D. Chyun, S. Song, R. S. Sherwin, W. V. Tamborlane, F. A. Lee, M. A. Pfeifer, F. Rife, F. J. T. Wackers, and L. H. Young Cardiac responses to insulin-induced hypoglycemia in nondiabetic and intensively treated type 1 diabetic patients Am J Physiol Endocrinol Metab, November 1, 2001; 281(5): E1029 - E1036. [Abstract] [Full Text] [PDF]

				G. de Simone, F. Pasanisi, and F. Contaldo Link of Nonhemodynamic Factors to Hemodynamic Determinants of Left Ventricular Hypertrophy Hypertension, July 1, 2001; 38(1): 13 - 18. [Abstract] [Full Text] [PDF]

				J. M. Richey, M. Ader, D. Moore, and R. N. Bergman Angiotensin II induces insulin resistance independent of changes in interstitial insulin Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E920 - E926. [Abstract] [Full Text] [PDF]

				P. Van De Borne, M. Hausberg, R. P. Hoffman, A. L. Mark, and E. A. Anderson Hyperinsulinemia produces cardiac vagal withdrawal and nonuniform sympathetic activation in normal subjects Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1999; 276(1): R178 - R183. [Abstract] [Full Text] [PDF]

				P. J. Arciero, D. L. Smith, and J. Calles-Escandon Effects of short-term inactivity on glucose tolerance, energy expenditure, and blood flow in trained subjects J Appl Physiol, April 1, 1998; 84(4): 1365 - 1373. [Abstract] [Full Text] [PDF]

				A. Natali, A. Gastaldelli, A. Q. Galvan, A. M. Sironi, D. Ciociaro, G. Sanna, P. Rosenzweig, and E. Ferrannini Effects of acute alpha 2-blockade on insulin action and secretion in humans Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E57 - E64. [Abstract] [Full Text] [PDF]

				E. Ferrannini, A. Natali, B. Capaldo, M. Lehtovirta, S. Jacob, and H Yki-Jarvinen Insulin Resistance, Hyperinsulinemia, and Blood Pressure : Role of Age and Obesity Hypertension, November 1, 1997; 30(5): 1144 - 1149. [Abstract] [Full Text]

				J. R. Sowers Insulin and Insulin-Like Growth Factor in Normal and Pathological Cardiovascular Physiology Hypertension, March 1, 1997; 29(3): 691 - 699. [Full Text]

				M. Hausberg, R. P. Hoffman, V. K. Somers, C. A. Sinkey, A. L. Mark, and E. A. Anderson Contrasting Autonomic and Hemodynamic Effects of Insulin in Healthy Elderly Versus Young Subjects Hypertension, March 1, 1997; 29(3): 700 - 705. [Abstract] [Full Text]

				M. K. McKay and R. L. Hester Role of Nitric Oxide, Adenosine, and ATP-Sensitive Potassium Channels in Insulin-Induced Vasodilation Hypertension, August 1, 1996; 28(2): 202 - 208. [Abstract] [Full Text]